Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
11C-Choline PET/CT and PET/MR for Recurrent Prostate Cancer
NCT02260817Phase 3Completed
- Sponsor
- Global Isotopes
- Start
- Oct 2014
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of choline C 11 in prostate cancer (PCa), sponsored by Global Isotopes. Started Oct 2014; status: completed.
02
Drugs
choline C 11
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02260817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02260817.